On the availability of intramitochondrial carbamoylphosphate for the extramitochondrial biosynthesis of pyrimidines.
D000255:Adenosine Triphosphate / Q000494:pharmacology / Q000502:physiology; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001224:Aspartic Acid / Q000096:biosynthesis / Q000494:pharmacology; D001639:Bicarbonates / Q000378:metabolism; D001692:Biological Transport; D002219:Carbamates / Q000378:metabolism*; D002247:Carbon Isotopes; D003864:Depression, Chemical; D004355:Drug Stability; D004926:Escherichia coli / Q000201:enzymology; D006027:Glycosides / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D009952:Ornithine / Q000494:pharmacology; D010756:Phosphoric Acids / Q000378:metabolism*; D011743:Pyrimidines / Q000096:biosynthesis*; D051381:Rats; D012995:Solubility; D013268:Stimulation, Chemical; D014166:Transferases / Q000494:pharmacology
D000963:Antimetabolites; D001639:Bicarbonates; D002219:Carbamates; D002247:Carbon Isotopes; D006027:Glycosides; D010756:Phosphoric Acids; D011743:Pyrimidines; D001224:Aspartic Acid; D000255:Adenosine Triphosphate; D009952:Ornithine; D014166:Transferases